The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
170 jobs Number of planned job creations
Announcement Date
3 November 2008
Employment effect (start)
Foreseen end date
30 November 2011
Description
US-owned pharmaceuticals company Merck Sharp and Dohme (MSD) has announced the creation of 170 new jobs at a new vaccine facility plant to be based in Carlow. The new high skilled posts are to include experts in science, engineering, pharmacy, microbiology, technology, IT, and management and recruitment will commence in 2009 and will be completed in 2011. 300 jobs will also be generated, possibly divided among several companies, in the construction phase. MSD currently employs 530 people in Ireland.
Sources
4 November 2008: The Irish Examiner
Citation
Eurofound (2008), Merck Sharp and Dohme, Business expansion in Ireland, factsheet number 67328, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/67328.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
